Search and volunteer to participate in these available studies at UB. Your participation in research doesn't just benefit you, it helps advance healthcare for our entire community.

Highlighted Searches
Search Clinical Trials
Filter on any fields below
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Showing 21 - 30 of 313 Clinical Trials
Description:
This study enrolls adults who have had a brain hemorrhage within the last 7 days. The purpose of the study is to learn whether it is better to keep taking or stop taking the medication statin after having a brain bleed. Read More
Eligibility:
Adults ages 50+.
Have had bleeding in the brain (brain hemorrhage) within the last 7 days.
Were taking a statin drug.
People who may be eligible for this study will be contacted by study staff directly. Eligible participants will be inpatients of Buffalo General/Gates Vascular Institute.
Description:
This study enrolls adults with schizophrenia who are currently in a treatment program for schizophrenia and your clinician is prescribing a Long Read More
Eligibility:
Adults ages 18+.
Diagnosis of schizophrenia.
Have just started treatment with one of four atypical Long Acting Injectable (LAI) medications (ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA or RISPERDAL CONSTA)
Contact(s)
SEVIE KANDEFER
sk293@buffalo.edu
+1 716-898-4038
Description:
This study enrolls adults with a blockage in an artery in their heart that needs to be tested to determine if it should be treated. The purpose of this study is to collect data and measurements to find out if you need you need an interventional procedure to open your blood vessel or artery. Read More
Eligibility:
Adults ages 18+.
Have at least 1 non-stented lesion in 1 or more major epicardial vessels of 40-90% angiographic stenosis.
Contact(s)
ROBIN STEIN
rmstein3@buffalo.edu
+1 716-888-4859
Description:
This study enrolls adults with Congenital Adrenal Hyperplasia. The purpose of this study is to see if an investigational drug called tildacerfont is safe and effective in reducing the level of certain hormones in your body. Read More
Eligibility:
Adults ages 18-55.
Has a documented historical diagnosis of classic Congenital Adrenal Hyperplasia (CAH)
Contact(s)
Arsalan Mustafa
arsalanm@buffalo.edu
+1 716-548-9493
Description:
This study enrolls people who have been diagnosed with a blood clot blocking an artery in their brain (stroke). The blocked artery is opened by removing the blood clot using a small catheter (thin tube) device that is inserted into an artery through your arm or leg that leads to your brain. The purpose of this study is to find out if this specific new investigational catheter (ZOOM) leads to improved outcomes at 90 days. Read More
Eligibility:
Adults ages 18+
Diagnosed with a stroke
Nonpregnant females
Contact(s)
JENNIFER GAY
jgay@ubns.com
+1 716-888-4811
Description:
This study enrolls adults with nonalcoholic steatohepatitis (NASH). The purpose of this study is to learn about how much a medication called tirzepatide can help people with this condition. Read More
Eligibility:
Adults ages 18-80.
Overweight or obese.
Diagnosis of NASH by liver biopsy in the past 6 months.
Have fibrosis stage 2 or 3.
Contact(s)
JENNA SUNDERLIN
jls39@buffalo.edu
+1 716-888-4842
Description:
This study enrolls people who have been diagnosed with Tricuspid Regurgitation (TR). The purpose of this study is to look at the safety and effectiveness of this new investigational device compared to the standard medical treatment. Read More
Eligibility:
Adults ages 18+
Diagnosed with Tricuspid Regurgitation/Insufficiency
Contact(s)
COURTNEY BISHOP
cabishop@buffalo.edu
Description:
This is a 26-week open-label study to evaluate the safety and effectiveness of the study drug in the treatment of pediatric participants with schizophrenia or bipolar I disorder. Read More
Eligibility:
Males and females ages 13 to 18 with schizophrenia or 10 to 18 years of age with bipolar I disorder may be eligible for the study.
Contact(s)
SEVIE KANDEFER
sk293@buffalo.edu
+1 716-898-4038
Description:
This study enrolls women who will be having a hysterectomy. Our goal is to create a non-opioid pain medication plan that will make opioid pain medications less needed after surgery. Read More
Eligibility:
Adults ages 18+.
Women undergoing a robotic hysterectomy who do not have current opioid prescription or current opioid addiction.
Contact(s)
Sarah Andres
seandres@buffalo.edu
+1 888-888-8888
Description:
This study enrolls children and young adults with congenital anomalies of the kidney and urinary tract (CAKUT). The purpose of the study is to learn which gene mutation(s) may be responsible for this condition and to eventually find a gene therapy to treat this condition. Read More
Eligibility:
Children and young adults ages 0-21 years old with CAKUT (congenital anomalies of the kidney and urinary tract) seen at Oshei Children's Hospital
Patient's family member without CAKUT.
Contact(s)
Haiping Qiao
hqiao@buffalo.edu
+1 716-323-0055
Showing 21 - 30 of 313 Clinical Trials
Not finding what you are looking for? Add your profile to the Buffalo Research Registry or ResearchMatch to be matched with future studies.